BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2004
View Archived Issues
Three novel series of vanilloid VR1 antagonists presented by GSK
Read More
New melanocortin MC4 agonists under study at Merck
Read More
Abbott researchers describe new dopamine D3 ligands for schizophrenia and depression
Read More
Novel Chk1 inhibitors and their use covered by AstraZeneca patent
Read More
New tubulin polymerization inhibitors prepared and tested at Aventis
Read More
AstraZeneca scientists design novel gamma-secretase inhibitors
Read More
Novel CDK2/CDK5 inhibitors claimed by IRM researchers
Read More
Bile acid transport inhibitors may lower plasma cholesterol levels
Read More
A3 adenosine receptor agonist inhibits the development of experimental arthritis in vivo
Read More
Novel hypoxia-targeting agents for tumor therapy
Read More
Orphan drug designation for BAY-43-9006 for renal cell carcinoma
Read More
European launch for Angiox
Read More
Further restructuring at Savient
Read More
Aridol asthma test meets endpoints in phase III study
Read More
Provenge extends survival of advanced prostate cancer patients in phase III study
Read More
Tumor responses in phase I study of Proxinium for head and neck cancer
Read More
Recent progress with Imvamune
Read More
ARRIVE 2 registry program begins enrollment
Read More
Enrollment completed in phase II Pneumocystis carinii study of DB-289
Read More
Delay to roflumilast regulatory filing in U.S.
Read More
Roche and Pharmasset to develop new generation HCV therapies
Read More
Mimpara approved in Europe
Read More
BAL-4079 enters phase III for severe chronic hand dermatitis
Read More
Novel platelet-specific nitric acid donor inhibits experimental thrombogenesis
Read More
Insulin enhances memory, mood in healthy subjects
Read More
OPC-28326 reduces the frequency of secondary RP attacks in patients with scleroderma
Read More
BPC-157 improves myofibrotic contracture in animal model
Read More
Mechanism of action of DMARD T-614
Read More
New data on the effects of the antisense inhibitor ISIS-301012
Read More
Abatacept effective in RA patients inadequately responding to methotrexate or TNF-alpha inhibitors
Read More
Laquinimod pharmacokinetics assessed in relapsing multiple sclerosis patients
Read More
Interleukin-12 produces responses in non-Hodgkin's lymphoma patients
Read More